Its the raise that brought in the buyers that are pushing it up now.
There would have been some big buyers not able to get set because of the low liquidity of the stock. They were able to get set at a good price and here we are now 6 or 7 weeks later. We are now financially set for the completion of phase 2 and running ancillary studies for dementia, TBI and HIA.
I don't think there will be another raise if results are looking good. There will be some corporate action, partnerships etc.
Ann: DSMB Confirms Safety of First Patients Dosed, page-12
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.3¢ |
Change
-0.008(0.95%) |
Mkt cap ! $96.79M | |||
| Open | High | Low | Value | Volume |
| 79.0¢ | 80.0¢ | 74.0¢ | $356.6K | 463.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | 77.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.59pm 28/06/2024 (20 minute delay) ? |
| AGN (ASX) Chart |